Journal of Substance Abuse Treatment
Volume 28, Issue 3 , Pages 273-280 , April 2005

Adoption of naltrexone to treat alcohol dependence

  • Bret E. Fuller, Ph.D.

      Affiliations

    • Department of Public Health and Preventive Medicine, Oregon Health and Science University, Portland, OR 97239, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 503 494 6553; fax: +1 503 494 4981.
    • ,
  • Traci Rieckmann, Ph.D.

      Affiliations

    • Department of Public Health and Preventive Medicine, Oregon Health and Science University, Portland, OR 97239, USA
    • ,
  • Dennis McCarty, Ph.D.

      Affiliations

    • Department of Public Health and Preventive Medicine, Oregon Health and Science University, Portland, OR 97239, USA
    • ,
  • Kevin W. Smith, M.A.

      Affiliations

    • Survey Research Center, New England Research Institutes, Watertown, MA 02472, USA
    • ,
  • Helen Levine, Ph.D.

      Affiliations

    • Levine and Associates, Boston, MA, USA

Received 26 March 2004 ,Revised 9 January 2005 ,Accepted 23 February 2005.

References 

  1. Alexander J, Lemak CH. The effects of managed care on administrative burden in outpatient substance abuse treatment facilities. Medical Care. 1997;35:1060–1068
  2. Alexander JA, Lemak CH. Managed care penetration in outpatient substance abuse treatment units. Medical Care Research and Review. 1997;54:490–507
  3. Bollen KA. Structural equations with latent variables. New York: Wiley; 1989;
  4. Brown B, Flynn P. The federal role in drug abuse technology transfer: A history and perspective. Journal of Substance Abuse Treatment. 2002;22:245–257
  5. D'Aunno T, Fuller RK, Branchey L, Brightwell DR, Derman RM, Emrick CD, et al. Disulfiram treatment of alcoholism: A Veterans Administration Cooperative Study. Journal of the American Medical Association. 1986;256:1449–1455
  6. Forman RF, Bovasso G, Woody G. Staff beliefs about addiction treatment. Journal of Substance Abuse Treatment. 2001;21:1–9
  7. Hatcher L. A step-by-step approach to using the SAS system for factor analysis and structural equation modeling. Cary, NC: SAS Institute; 1994;
  8. Institute of Medicine . Bridging the gap between practice and research: Forging partnerships with community-based drug and alcohol treatment. Washington, DC: National Academy Press; 1998;
  9. Kranzler HR, Van Kirk J. Efficacy of naltrexone and acamprosate for alcoholism treatment: A meta-analyses. Alcoholism: Clinical and Experimental Research. 2001;25:1335–1341
  10. Lemak CH, Alexander JA. Managed care and outpatient substance abuse treatment intensity. Journal of Behavioral Health Services & Research. 2001;28:12–29
  11. Mark TL, Kranzler HR, Poole VH, Hagen CA, McLeod C, Crosse S. Barriers to the use of medications to treat alcoholism. American Journal on Addictions. 2003;12:281–295
  12. Mark TL, Kranzler HR, Song X, Bransberger P, Poole VH, Crosse S. Physicians' opinions about medications to treat alcoholism. Addiction. 2003;98:617–626
  13. O'Malley SS, Jaffe A, Change G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Archives of General Psychiatry. 1992;49:881–887
  14. Petrakis IL, Leslie D, Rosenheck R. Use of naltrexone in the treatment of alcoholism nationally in the Department of Veterans Affairs. Alcoholism: Clinical and Experimental Research. 2003;27:1780–1784
  15. Rogers EM. Diffusion of innovations. 4th ed.. New York: Free Press; 1995;
  16. Roman PM, Johnson JA. Adoption and implementation of new technologies in substance abuse treatment. Journal of Substance Abuse Treatment. 2002;22:211–218
  17. SAS Institute . SYS/STAT user's guide version 8. Cary, NC: SAS Publishing; 1999;
  18. Simpson DD. A conceptual framework for transferring research to practice. Journal of Substance Abuse Treatment. 2002;22:171–182
  19. Streeton C, Whelan G. Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: A meta-analysis of randomized controlled trials. Alcohol and Alcoholism. 2001;36:544–552
  20. Swift RM, Duncan D, Nirenberg T, Femino J. Alcoholic patients' experience and attitudes on pharmacotherapy for alcoholism. Journal of Addictive Diseases. 1998;17:35–47
  21. Thomas CP, Wallack S, Lee SS, McCarty D, Swift R. Research to practice: Adoption of naltrexone in alcoholism treatment. Journal Substance Abuse Treatment. 2003;24:1–11
  22. Volpicelli J, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry. 1992;49:876–880

☆ This research was made possible by a grant from NIAAA (RO1-AA11363).

PII: S0740-5472(05)00043-7

doi: 10.1016/j.jsat.2005.02.003

Journal of Substance Abuse Treatment
Volume 28, Issue 3 , Pages 273-280 , April 2005

Article Tools

* Image Usage & Resolution